Shares of Evoke plc (LON:EVOK – Get Free Report) dropped 10% during mid-day trading on Thursday . The stock traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares traded hands during mid-day trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Wall Street Analysts Forecast Growth
A number of brokerages have recently commented on EVOK. Berenberg Bank lowered their target price on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a research note on Wednesday, December 4th. Jefferies Financial Group restated a “buy” rating and issued a GBX 140 ($1.81) price objective on shares of Evoke in a research report on Monday, December 16th.
Read Our Latest Research Report on Evoke
Evoke Stock Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last posted its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. Analysts predict that Evoke plc will post 12.7648305 EPS for the current fiscal year.
Insider Activity
In other news, insider Andrea Gisle Joosen bought 14,572 shares of Evoke stock in a transaction on Tuesday, January 28th. The stock was acquired at an average price of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). Company insiders own 27.00% of the company’s stock.
Evoke Company Profile
Read More
- Five stocks we like better than Evoke
- Trading Stocks: RSI and Why it’s Useful
- MarketBeat Week in Review – 03/24 – 03/28
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Utilities Stocks Explained – How and Why to Invest in Utilities
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.